Can Desmoplasia be a Biomarker for Cancer Diagnosis and Prognosis?
Yes, desmoplasia can serve as a biomarker for both cancer diagnosis and prognosis. The extent of desmoplasia in tumor samples can provide valuable information about the aggressiveness of the cancer and the likely response to treatment. For instance, high levels of desmoplasia are often correlated with poor prognosis and treatment resistance, making it a critical factor in clinical decision-making.
